AMGN
AMGEN INC
Health Care·Biotechnology·UNITED STATES
$437.23
MCap $236.4B
as of 2026-09-04
Total
B4w
Fund
C3w
Quant
A4w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-09-04
MIDOS SI
-0.60
Sentiment 83.5%
−3 oversold0+3 overbought
Signal
NEUTRAL
Actual
$437.23
Adaptive Mean
$443.12
-5.89 vs mean
Adaptive σ
4.93
MIDOS BB
$433.26 – $452.98
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-09-04
Composite Z
+0.41
ROE
91.5%
Z +1.97
Rev Gr
9.5%
Z -0.25
EPS Gr
64.9%
Z +0.26
OPM Gr
6.0%
Z +0.43
FCF Yld
3.7%
Z +0.35
EPS Surp
0.1%
Z -0.01
EPS 3mo Δ
2.5%
Z +0.15
Fwd P/E
17.91
Z —
PEGY
0.06
Cheap (GARP)
Momentum (Risk-Adjusted Alpha)
as of 2026-09-04
Q3M
19.20
Q6M
5.93
Q12M
8.71
MA 30/100
1.136
Bullish (MA30 > MA100)
α (Jensen)
0.8491
β (12M)
0.50
σ (12M)
0.276
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
90%
Q Percentile
94%
Divergence
-4.6
Tier
ALIGNED
Fundamentals and momentum roughly in line.
Kirkpatrick RS & Persistence
RS
3.6
RS Pctl
66%
RS Decile
D7
Persistence
4w
at grade B
Options / OI Analysis
No options or Williams data available for this ticker.